郑州微飒生物科技有限责任公司 咨询热线：0371-88821766
行业动态

行业动态

追踪行业前沿，洞察产业趋势

药效评价Sphingosine 1-phosphate receptor 1 (S1P(1)) upregulation and amelioration of experimental autoimmune encephalomyelitis by an S1P(1) antagonist.

期刊：Molecular pharmacology发表年份：2013作者：Stuart M Cahalan; Pedro J Gonzalez-Cabrera; Nhan Nguyen; Miguel Guerrero; Elizabeth A George Cisar; Nora B Leaf; Steven J Brown; Edward Roberts; Hugh Rosen
阅读更多 →

药效评价Design, synthesis, and biological evaluation of a series of benzo[de][1,7]naphthyridin-7(8H)-ones bearing a functionalized longer chain appendage as novel PARP1 inhibitors.

期刊：Journal of medicinal chemistry发表年份：2013作者：Na Ye; Chuan-Huizi Chen; Tiantian Chen; Zilan Song; Jin-Xue He; Xia-Juan Huan; Shan-Shan Song; Qiufeng Liu; Yi Chen; Jian Ding; Yechun Xu; Ze-Hong Miao; Ao Zhang
阅读更多 →

药效评价Segregation of family A G protein-coupled receptor protomers in the plasma membrane.

期刊：Molecular pharmacology发表年份：2013作者：Anthony Gavalas; Tien-Hung Lan; Qiuju Liu; Ivan R Corrêa; Jonathan A Javitch; Nevin A Lambert
阅读更多 →

药效评价A high-throughput screening assay for determining cellular levels of total tau protein.

期刊：Current Alzheimer research发表年份：2013作者：Seameen J Dehdashti; Wei Zheng; Joel R Gever; Robert Wilhelm; Dac-Trung Nguyen; Gurusingham Sittampalam; John C McKew; Christopher P Austin; Stanley B Prusiner
阅读更多 →